Karyopharm - oncology











































Blame the BOD and our big institutional holders for not vetting out our current CEO and CCO.

Neither held their current positions prior.

So let me get this straight...they roll MK only to bring in equally unqualified people in key positions like CEO and CCO? How does that make any sense?
 












Blame the BOD and our big institutional holders for not vetting out our current CEO and CCO.

Neither held their current positions prior.

So let me get this straight...they roll MK only to bring in equally unqualified people in key positions like CEO and CCO? How does that make any sense?

Paulson is garbage.